Skip to main content
Caplight Logo









Pear Bio

Pear Bio

Private
LondonHealthcare & Life Scienceshttps://pearbio.com/

Last Round

Series A

May 14, 2023

Total Funding Raised

$19.6M

Company Overview

Pear Bio is a biotechnology company that provides a computational biology platform to guide personalized cancer treatment and drug discovery using 3D cell cultures and computer vision.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Computer Vision, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

organ-on-a-chipprecision medicinefunctional precision medicinetumor modelingcomputer visiondrug discoverycancer drug developmentpredictive biomarkerspatient stratificationmicrotumordrug efficacy testinglab-on-a-chipai drug discoveryin vitro drug testingdigital twin

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pear Bio Comparables

Compare Pear Bio with similar companies based on industry and business-model similarity.

Pear Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xilis
88%
Curesponse
85%
Vivodyne
82%

Pear Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 14, 2023
SeedSep 27, 2021
AcceleratorOct 10, 2019

Key People

Founding team and executive leadership

Duleek Ranatunga

Founder, CEO

Founding Team

John Curran

COO Laboratory Director

Executive Team

Pear Bio Investors

Notable investors and investment history

Pear Bio investors
InvestorRounds
Hoxton VenturesPre Seed, Seed, Series A
Fly VenturesSeed, Series A
Crista Galli VenturesPre Seed, Seed, Series A
RebelBioAccelerator
SOSVSeed, Accelerator, Series A
Octopus VenturesSeries A
The Compound Capital FundSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 62% MoM.

Pear Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pear Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pear Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range10
Year Founded2017
Last FundingMay 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?